Varicella Zoster (HHV-3) Infections Market is driven by Vaccine Innovations
The Varicella Zoster (HHV-3) Infections Market encompasses vaccines and antiviral therapeutics designed to prevent and treat chickenpox and shingles caused by the varicella-zoster virus. Leading products include live-attenuated vaccines, recombinant subunit vaccines, and nucleoside analog antivirals, each offering distinct advantages in safety, immunogenicity, and ease of administration....
0 Kommentare 0 Anteile 194 Ansichten 0 Vorschau